by The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.Read MoreVaccination and Immunization, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Regulation and Deregulation of Industry, Viruses, Centers for Disease Control and Prevention, Food and Drug Administration, Moderna Inc, Novavax Inc, Pfizer Inc, your-feed-healthcareNYT > Health
